Globus Medical, Inc. (NYSE: GMED) will release its first-quarter 2025 financial results on Thursday, May 8, 2025, after ...

Globus Medical Inc. (NYSE:GMED) shares have reached an unprecedented peak, touching an all-time high of $93.68. With a market capitalization of $12.7 billion and an impressive revenue growth of ...

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. This medical device company has seen a nice streak of beating earnings ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

In the preceding three months, 5 analysts have released ratings for Globus Medical GMED, presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ...

The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio. The deal was first announced in February, and Nevro was valued ...